YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.10
+0.60 (3.64%)
Jul 16, 2025, 4:08 PM HKT

YiChang HEC ChangJiang Pharmaceutical Company Description

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People’s Republic of China.

It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services.

The company’s product portfolio includes Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It sells its products to hospitals and medical institutions through a network of distributors.

The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015.

The company was incorporated in 2001 and is based in Yichang, China.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
CountryChina
Founded2001
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees4,861
CEOJuncai Jiang

Contact Details

Address:
No. 38, Binjiang Road
Yichang
China
Websitehec-changjiang.com

Stock Details

Ticker Symbol1558
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE1000023R6
SIC Code2834

Key Executives

NamePosition
Juncai JiangGM and Executive Director
Qiang Zhang CPAChief Financial Officer and Head of Finance Department
Danjin WangDeputy GM and Executive Director
Shuang LiDeputy GM and Executive Director
Hao ChenExecutive Director
Qiyun PengJoint Company Secretary
Yangui ChenHead of the Sales Department
Shengchao WangChief of Quality Division and Employee Representative Supervisor
Wai Chiu Wong C.P.A., CTP, FCSJoint Company Secretary